Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
January 21, 2019

Kyn Therapeutics, Celgene partner on immuno-oncology therapies development

Kyn Therapeutics, a US-based clinical-stage biotech company, has entered into a global collaboration with biopharma major Celgene to develop immuno-oncology therapies.

Image: Kyn Therapeutics, Celgene to collaborate on immuno-oncology therapies. Photo: courtesy of Photokanok/FreeDigitalPhotos.net.